Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer

被引:57
作者
Klotz, T
Bloch, W
Jacobs, G
Niggemann, S
Engelmann, U
Addicks, K
机构
[1] Univ Cologne, Dept Urol, D-50925 Cologne, Germany
[2] Univ Cologne, Inst Anat 1, D-50925 Cologne, Germany
关键词
D O I
10.1016/S0090-4295(99)00212-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Nitric oxide (NO) is synthesized by the enzyme family of NO synthases (NOS) and plays an important role in tumor growth and angiogenesis. NO generation by inducible NOS (INOS) also influences the cytotoxicity of macrophages and tumor-induced immunosuppression. Before now, the expression of INOS and constitutive NOS in bladder carcinoma tissue had not been determined. Methods, Bladder carcinoma tissue specimens were procured from 18 patients (mean age 69.7 years) undergoing transurethral resection. In every patient, tumor biopsies were compared with biopsies of benign bladder regions. Histochemical NADPH-diaphorase staining and NOS immunohistochemistry were performed on all tissue specimens. Results. Positive NADPH-diaphorase staining was detected in all sections from bladder carcinoma tissue. NOS immunohistochemistry showed a different pattern. The malignant epithelial cells were highly iNOS positive. Specimens of bladder mucosa outside of the malignant regions showed only a weak positive iNOS immunostaining. The endothelial cells of abundant precapillary vessels in the stroma of bladder tumors showed a highly positive endothelial NOS (eNOS) immunostaining compared with the stroma of nonmalignant bladder tissue. Neuronal NOS immunoreactivity was only found in nitrinergic fibers in the fibromuscular stroma, Conclusions. Bladder carcinoma tissue had a high INOS content; benign tissue did not. NO generation from iNOS in the malignant epithelium and from eNOS in tumor stroma may play different roles in tumor angiogenesis and tumor-induced immunosuppression. (C) 1999, Elsevier Science Inc.
引用
收藏
页码:416 / 419
页数:4
相关论文
共 15 条
[1]   INHIBITORS OF NITRIC-OXIDE SYNTHASE SELECTIVELY REDUCE FLOW IN TUMOR-ASSOCIATED NEOVASCULATURE [J].
ANDRADE, SP ;
HART, IR ;
PIPER, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) :1092-1095
[2]  
Campbell SC, 1998, CANCER RES, V58, P1298
[3]   Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo [J].
Edwards, P ;
Cendan, JC ;
Topping, DB ;
Moldawer, LL ;
MacKay, S ;
Copeland, EM ;
Lind, DS .
JOURNAL OF SURGICAL RESEARCH, 1996, 63 (01) :49-52
[4]   Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer [J].
Gallo, O ;
Masini, E ;
Morbidelli, L ;
Franchi, A ;
Fini-Storchi, I ;
Vergari, WA ;
Ziche, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (08) :587-596
[5]   Nitric oxide synthase activity in human renal cell carcinoma [J].
Jansson, OT ;
Morcos, E ;
Brundin, L ;
Bergerheim, USR ;
Adolfsson, J ;
Wiklund, NP .
JOURNAL OF UROLOGY, 1998, 160 (02) :556-560
[6]   ROLES OF NITRIC-OXIDE IN TUMOR-GROWTH [J].
JENKINS, DC ;
CHARLES, IG ;
THOMSEN, LL ;
MOSS, DW ;
HOLMES, LS ;
BAYLIS, SA ;
RHODES, P ;
WESTMORE, K ;
EMSON, PC ;
MONCADA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) :4392-4396
[7]  
Klotz T, 1998, CANCER, V82, P1897, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.0.CO
[8]  
2-O
[9]  
LEJEUNE P, 1994, J IMMUNOL, V152, P5077
[10]  
MONCADA S, 1993, NEW ENGL J MED, V329, P2002